H
Hans L. Bock
Researcher at GlaxoSmithKline
Publications - 110
Citations - 3227
Hans L. Bock is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: Vaccination & Reactogenicity. The author has an hindex of 30, co-authored 110 publications receiving 3116 citations.
Papers
More filters
Journal ArticleDOI
Efficacy of Acellular Pertussis Vaccine in Early Childhood After Household Exposure
Heinz-J. Schmitt,Carl H. Wirsing von König,Albrecht Neiss,H Bogaerts,Hans L. Bock,Hermann Schulte-Wissermann,Manfred Gahr,Rainer Schult,Jens U. Folkens,Wolfgang Rauh,Ralf Clemens +10 more
TL;DR: Under conditions of intense household exposure, primary vaccination with acellular vaccine protected against pertussis until at least the time recommended for booster vaccination.
Journal ArticleDOI
Pertussis in adults: frequency of transmission after household exposure.
TL;DR: It is concluded that adults are often involved in the spread of pertussis, and that they can be susceptible to reinfection 20 years after a first pertussedis episode.
Journal ArticleDOI
Effect of climatic factors and population density on varicella zoster virus epidemiology within a tropical country.
Somsak Lolekha,Watcharee Tanthiphabha,Penpark Sornchai,Pensri Kosuwan,Sumit Sutra,Boonyarat Warachit,Suda Chup-Upprakarn,Yanee Hutagalung,John Weil,Hans L. Bock +9 more
TL;DR: In Thailand, climate is the main determinant of VZV seroprevalence and the delayed onset of natural immunity is more marked in warmer climate areas; population density is a secondary determinant; in the warmer areas, the pattern of adolescent and adult susceptibility was greater in rural than in urban areas.
Journal ArticleDOI
Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age
K. Zaman,David A. Sack,M. Yunus,Shams El Arifeen,Goutam Podder,Tasnim Azim,Stephen P. Luby,Robert F. Breiman,Kathleen M. Neuzil,Sanjoy K Datta,Andrée Delem,P.V. Suryakiran,Hans L. Bock +12 more
TL;DR: Oral live-attenuated human rotavirus vaccine RIX4414 (Rotarix) and oral polio vaccine (OPV) was assessed and Rix4414 vaccine was immunogenic when co-administered with OPV and did not interfere with OPv seroprotection rates.
Journal ArticleDOI
Symptoms and complications of pertussis in adults.
TL;DR: This is the first report to describe sweating attacks as symptom of pertussis, and micro-biological diagnostics should be vigorously applied to all symptomatic contacts of a patient with pertussi but also to all patients with long lasting cough — irrespective of age.